Triamterene

Specifications

396-01-0CAS Number

206-904-3EC Number

6-phenylpteridine-2,4,7-triamineIUPAC Name

C12H11N7Chemical Formula

253.26 g/molMolecular Weight

triamterene; 396-01-0; 6-phenylpteridine-2,4,7-triamine; 2,4,7-Triamino-6-phenylpteridine; Dyrenium; Dytac; Pterophene; Triamteren; Diurene; Noridil; Pterofen; Taturil; Teridin; Triteren; Ademine; Jatropur; Noridyl; Triamteril; Urocaudal; Teriam; Diren; Ditak; Dyren; Tri-Span; 6-Phenyl-2,4,7-pteridinetriamine; 2,4,7-Pteridinetriamine, 6-phenyl-; Ademin(e); SK&F 8542; Triamterenum; Triamterena; SKF 8542; 6-Phenyl-2,4,7-triaminopteridine; NSC-77625; DTXSID6021373; Pteridine, 2,4,7-triamino-6-phenyl-; 2,4,7-Triamino-6-fenilpteridina; Triamtereno; SK-8542; SK&F-8542; CHEBI:9671; WS821Z52LQ; NSC77625; NSC-639359; DTXCID001373; 5-26-17-00447 (Beilstein Handbook Reference); NSC639359; Triamterene Capsules; RefChem:58580; C03DB02; 206-904-3; Ademin; Triampur; Trispan; C12H11N7; MFCD00006708; Triamterene (Standard); Diucelpin; Diuteren; Masuharmin; Triamizide; Triamthiazid; Amteren; Dinazide; Diutensat; Dyberzide; Dytenzide; Esiteren; Hidiurese; Hydrene; Hypertorr; Jenateren; Kalspare; Nephral; Renezide; Reviten; Tricilone; Triurene; Uretren; Diarol; Isobar; Trizid; Anjal; Dazid; Turfa; Apo-triazide; Thiazid Wolff; NCI-C56042; NCGC00016016-10; CAS-396-01-0; Triazide; Fluss 40; SALI-PUREN; Triamterenum [INN-Latin]; Triamterena [INN-Spanish]; Dyrenium (TN); NSC 77625; BRN 0266723; CCRIS 5872; Pteridine deriv. 11; HSDB 3405; 2,4,7-Triamino-6-fenilpteridina [Italian]; NCI C56042; SR-01000002968; EINECS 206-904-3; NSC 639359; UNII-WS821Z52LQ; Adernine; Pterophene;; Triamterene?; AI3-60017; Urocaudal;; Dyrenium;; Jatropur;; Pterofen;; Triampur;; Triamterene CRS; Dytac;; Tri-Span;; Prestwick_480; Dyazide (Salt/Mix); Triamterene [USAN:USP:INN:BAN:JAN]; Spectrum_000508; Triamterene, >=99%; TRIAMTERENE [MI]; Prestwick0_000034; Prestwick1_000034; Prestwick2_000034; Prestwick3_000034; Spectrum2_000938; Spectrum3_001372; Spectrum4_000366; Spectrum5_001034; Lopac-T-4143; TRIAMTERENE [INN]; TRIAMTERENE [JAN]; TRIAMTERENE [HSDB]; TRIAMTERENE [IARC]; TRIAMTERENE [USAN]; CHEMBL585; Epitope ID:613460; T 4143; TRIAMTERENE [VANDF]; NCIOpen2_004741; TRIAMTERENE [MART.]; Lopac0_001196; Oprea1_825704; SCHEMBL40707; BSPBio_000127; BSPBio_002924; KBioGR_000831; KBioSS_000988; TRIAMTERENE [USP-RS]; TRIAMTERENE [WHO-DD]; MLS000069431; BIDD:GT0534; DivK1c_000433; SPECTRUM1500589; SPBio_000876; SPBio_002048; BDBM6644; BPBio1_000141; GTPL4329; orb1225118; orb2281211; orb3025005; Triamterene (JP18/USP/INN); 2,7-Triamino-6-phenylpteridine; 6-Phenyl-2,7-triaminopteridine; SCHEMBL10586653; SCHEMBL29531410; HMS501F15; HY-B0575R; KBio1_000433; KBio2_000988; KBio2_003556; KBio2_006124; KBio3_002144; TRIAMTERENE [ORANGE BOOK]; NINDS_000433; HMS1568G09; HMS2092O17; HMS2095G09; HMS2232B04; HMS3259C08; HMS3263P13; HMS3371D10; HMS3652E10; HMS3712G09; HMS5082A10; Pharmakon1600-01500589; TRIAMTERENE [EP MONOGRAPH]; TRIAMTERENE [USP IMPURITY]; 2,7-Pteridinetriamine, 6-phenyl-; Pteridine,4,7-triamino-6-phenyl-; TRIAMTERENE [USP MONOGRAPH]; DYAZIDE COMPONENT TRIAMTERENE; HY-B0575; MAXZIDE COMPONENT TRIAMTERENE; MSK10265; Tox21_110283; Tox21_202021; Tox21_302833; Tox21_501196; BBL023360; CCG-40090; EBC-03774; NSC757367; s4080; SBB017574; STK300348; AKOS003790819; Tox21_110283_1; DB00384; FT28388; LP01196; NC00544; NSC-757367; SDCCGSBI-0051163.P004; IDI1_000433; SMP1_000147; NCGC00016016-01; NCGC00016016-02; NCGC00016016-03; NCGC00016016-04; NCGC00016016-05; NCGC00016016-06; NCGC00016016-07; NCGC00016016-08; NCGC00016016-09; NCGC00016016-11; NCGC00016016-12; NCGC00016016-13; NCGC00016016-14; NCGC00016016-15; NCGC00016016-16; NCGC00016016-18; NCGC00016016-23; NCGC00016016-28; NCGC00016016-29; NCGC00023458-03; NCGC00023458-04; NCGC00023458-05; NCGC00023458-06; NCGC00023458-07; NCGC00256495-01; NCGC00259570-01; NCGC00261881-01; AC-14066; AS-12471; SMR000059118; ST093702; SBI-0051163.P003; DB-049442; AB00052116; CS-0695001; EU-0101196; NS00010256; SW196688-3; Triamterene 1.0 mg/ml in Dimethyl Sulfoxide; D00386; D95706; EN300-119540; WLN: T66 BN DN GN JNJ CZ EZ HR& IZ; 2,4-DIAMINO-6-PHENYL-7-PTERIDINYLAMINE; AB00052116_13; AB00052116_14; Q221520; SR-01000002968-2; SR-01000002968-4; SR-01000002968-6; BRD-K92049597-001-05-9; BRD-K92049597-001-10-9; BRD-K92049597-001-19-0; BRD-K92049597-001-20-8; Z275128596; 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine; Triamterene, British Pharmacopoeia (BP) Reference Standard; Triamterene, European Pharmacopoeia (EP) Reference Standard; Triamterene, United States Pharmacopeia (USP) Reference Standard; Triamterene, Pharmaceutical Secondary Standard; Certified Reference MaterialSynonyms